Key facts
- Anson Funds Management LP filed SCHEDULE 13G/A for SELLAS Life Sciences Group, Inc. Common Stock, par value $0.0001 per share (SLS).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Anson Funds Management LP | 4.9% | 7,481,178 | 0 | 7,481,178 | /s/ Tony Moore | Tony Moore, Manager | |
| Anson Management GP LLC | 4.9% | 7,481,178 | 0 | 7,481,178 | /s/ Tony Moore | Tony Moore, Manager | |
| Tony Moore | 4.9% | 7,481,178 | 0 | 7,481,178 | /s/ Tony Moore | Tony Moore, Manager | |
| Anson Advisors Inc. | 4.9% | 7,481,178 | 0 | 7,481,178 | /s/ Amin Nathoo | Amin Nathoo, Director | |
| Amin Nathoo | 4.9% | 7,481,178 | 0 | 7,481,178 | /s/ Amin Nathoo | Amin Nathoo, Director | |
| Moez Kassam | 4.9% | 7,481,178 | 0 | 7,481,178 | /s/ Moez Kassam | Moez Kassam, Director |
CIK / CUSIP context first